Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc. (CRVS)

Market is closed
News
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2024 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2024 Earnings Call Transcript

Operator: Good afternoon, everyone, and thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2024 Business Update and Financial Results Conference Call.

Keep Reading →

November 13th, 2024 - News Transcripts

13 Penny Stocks with Insider Buying in 2024

13 Penny Stocks with Insider Buying in 2024

In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks...

Keep Reading →

May 12th, 2024 - Hedge Funds Insider Trading News

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript

Operator: Good afternoon ladies and gentlemen and welcome to the Corvus Pharmaceuticals' Business Update and Reports First Quarter 2024 Financial Results Conference Call.

Keep Reading →

May 7th, 2024 - News Transcripts

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.14 EPS, expectations were $-0.14.

Keep Reading →

March 21st, 2024 - News Transcripts

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2023 Business Update and Financial Results Conference Call.

Keep Reading →

November 8th, 2023 - News Transcripts

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q2 2023 Earnings Call Transcript

Operator: Thank you for standing by. This is the conference operator. Welcome to the Corvus Pharmaceuticals Second Quarter 2023 Conference Call. [Operator Instructions].

Keep Reading →

August 10th, 2023 - News Transcripts

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2022 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen.

Keep Reading →

March 30th, 2023 - News Transcripts

10 Best Stocks to Buy Now According to Jeffrey Diehl's Adams Street Partners

10 Best Stocks to Buy Now According to Jeffrey Diehl's Adams Street Partners

In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl.

Keep Reading →

October 4th, 2022 - Hedge Fund Analysis Hedge Funds News

Top 10 Stock Picks of Jeffrey Diehl's Adams Street Partners

Top 10 Stock Picks of Jeffrey Diehl's Adams Street Partners

In this article, we will be taking a look at the top 10 stock picks of Jeffrey Diehl's Adams Street Partners.

Keep Reading →

June 30th, 2022 - Hedge Funds News

Why These 5 Stocks Are On the Move on Friday

Why These 5 Stocks Are On the Move on Friday

5. United States Steel Corporation (NYSE:X) is around 8% lower today after the company provided a third quarter  update.

Keep Reading →

September 17th, 2021 - Market Movers News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)